Literature DB >> 27116637

Power Analysis and Sample Size Determination in Metabolic Phenotyping.

Benjamin J Blaise1,2, Gonçalo Correia1, Adrienne Tin3, J Hunter Young4, Anne-Claire Vergnaud5, Matthew Lewis1,6, Jake T M Pearce1,6, Paul Elliott5, Jeremy K Nicholson1, Elaine Holmes1, Timothy M D Ebbels1.   

Abstract

Estimation of statistical power and sample size is a key aspect of experimental design. However, in metabolic phenotyping, there is currently no accepted approach for these tasks, in large part due to the unknown nature of the expected effect. In such hypothesis free science, neither the number or class of important analytes nor the effect size are known a priori. We introduce a new approach, based on multivariate simulation, which deals effectively with the highly correlated structure and high-dimensionality of metabolic phenotyping data. First, a large data set is simulated based on the characteristics of a pilot study investigating a given biomedical issue. An effect of a given size, corresponding either to a discrete (classification) or continuous (regression) outcome is then added. Different sample sizes are modeled by randomly selecting data sets of various sizes from the simulated data. We investigate different methods for effect detection, including univariate and multivariate techniques. Our framework allows us to investigate the complex relationship between sample size, power, and effect size for real multivariate data sets. For instance, we demonstrate for an example pilot data set that certain features achieve a power of 0.8 for a sample size of 20 samples or that a cross-validated predictivity QY(2) of 0.8 is reached with an effect size of 0.2 and 200 samples. We exemplify the approach for both nuclear magnetic resonance and liquid chromatography-mass spectrometry data from humans and the model organism C. elegans.

Entities:  

Mesh:

Year:  2016        PMID: 27116637     DOI: 10.1021/acs.analchem.6b00188

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  23 in total

1.  NMR Metabolomics Protocols for Drug Discovery.

Authors:  Fatema Bhinderwala; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

Review 2.  Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions.

Authors:  Emma E McGee; Rama Kiblawi; Mary C Playdon; A Heather Eliassen
Journal:  Curr Nutr Rep       Date:  2019-09

Review 3.  A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.

Authors:  Kedir N Turi; Lindsey Romick-Rosendale; Kelli K Ryckman; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

4.  Amino Acid Profile of Synovial Fluid Following Intra-articular Ankle Fracture.

Authors:  Elizabeth M Leimer; Laura M Tanenbaum; Dana L Nettles; Richard D Bell; Mark E Easley; Lori A Setton; Samuel B Adams
Journal:  Foot Ankle Int       Date:  2018-08-15       Impact factor: 2.827

5.  Statistical analysis in metabolic phenotyping.

Authors:  Benjamin J Blaise; Gonçalo D S Correia; Gordon A Haggart; Izabella Surowiec; Caroline Sands; Matthew R Lewis; Jake T M Pearce; Johan Trygg; Jeremy K Nicholson; Elaine Holmes; Timothy M D Ebbels
Journal:  Nat Protoc       Date:  2021-07-28       Impact factor: 13.491

6.  Wdfy3 regulates glycophagy, mitophagy, and synaptic plasticity.

Authors:  Eleonora Napoli; Alexios A Panoutsopoulos; Patricia Kysar; Nathaniel Satriya; Kira Sterling; Bradley Shibata; Denise Imai; David N Ruskin; Konstantinos S Zarbalis; Cecilia Giulivi
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-29       Impact factor: 6.960

Review 7.  Integrative metabolomics as emerging tool to study autophagy regulation.

Authors:  Sarah Stryeck; Ruth Birner-Gruenberger; Tobias Madl
Journal:  Microb Cell       Date:  2017-07-13

8.  Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients.

Authors:  Elodie Jobard; Olivier Trédan; Thomas Bachelot; Arnaud M Vigneron; Céline Mahier Aït-Oukhatar; Monica Arnedos; Maria Rios; Jacques Bonneterre; Véronique Diéras; Marta Jimenez; Jean-Louis Merlin; Mario Campone; Bénédicte Elena-Herrmann
Journal:  Oncotarget       Date:  2017-06-28

9.  Inter-laboratory reproducibility of an untargeted metabolomics GC-MS assay for analysis of human plasma.

Authors:  Yanping Lin; Gary W Caldwell; Ying Li; Wensheng Lang; John Masucci
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

Review 10.  Beyond genomics: understanding exposotypes through metabolomics.

Authors:  Nicholas J W Rattray; Nicole C Deziel; Joshua D Wallach; Sajid A Khan; Vasilis Vasiliou; John P A Ioannidis; Caroline H Johnson
Journal:  Hum Genomics       Date:  2018-01-26       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.